In addition, a single‐cell study on immune remodeling in gallbladder cancer found that senescent Tgm2+ fibroblasts altered the tumor microenvironment through SASP, resisted immunotherapy, and promoted tumor migration (Wang et al. 2022). The gene discussed is TGM2; the disease is gallbladder cancer.